The European Medicines Agency on Thursday approved an update to the product information for Novo Nordisk A/S’ NVO Wegovy, enabling the weight management drug to be delivered at controlled temperatures ... Yahoo Finance: Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU Benzinga on MSN: Novo Nordisk wins EU nod to ease Wegovy injection delivery The European Medicines Agency (EMA) has approved an update to the product information for Wegovy ® injection that allows the medicine to stay ... Managed Healthcare Executive: The FDA has approved Eli Lilly's oral GLP-1, Foundayo.

Context Explanation

Let the heated rivalry with oral Wegovy begin The FDA has approved Eli Lilly's oral GLP-1, Foundayo. Let the heated rivalry with oral Wegovy begin Novo Nordisk (NVO) stock is in focus as the EU eases the cold-chain requirement that obesity injection, Wegovy, should be subject to during delivery. Read more here.